Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s13239-017-0320-3 http://scihub22266oqcxt.onion/10.1007/s13239-017-0320-3 C5573759!5573759 !28721509     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28721509 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Cardiovasc+Eng+Technol 2017 ; 8 (3 ): 240-243 Nephropedia Template TP {{tp|p=28721509 |t=2017. Maintaining Patency of Vascular Access for Haemodialysis |pdf=|usr=}}{{28721509 }} gab.com Text Maintaining Patency of Vascular Access for Haemodialysis JO: Cardiovasc Eng Technol http://www.kidney.de/pget.php?&tw=1&pmid=28721509 #FOAvip All types of vascular access, a necessity for haemodialysis, are prone to thrombosis and if untreated this results in failure. Thrombosis results from the combination of impaired blood flow, endothelial and vessel wall injury and a propensity towards pro-coagulative states, either intrinsic or aggravated by dialysis or dehydration. The treatment of access thrombosis relies on removal of the clot (thrombectomy) and treatment of the underlying problem. In most cases this is stenosis secondary to neointimal hyperplasia which can occur early (failure to mature) or later. Pharmacological approaches have largely been shown to be ineffective at prevention of thrombosis. The mainstay of preventing access failure may be in surveillance and detecting stenosis prior to occlusion although the optimal protocol to achieve this remains undefined. Management of thrombosed access is via either surgical and radiological approaches. Multiple techniques and devices are available for thrombectomy and the choice is usually based on local expertise and availability rather than evidence as few trials have been performed to allow robust comparisons. This paper outlines the basis of access thrombosis and discusses the currently available techniques for treatment. Twit Text FOAVip Maintaining Patency of Vascular Access for Haemodialysis ????Cardiovasc Eng Technol http://www.kidney.de/pget.php?&tw=1&pmid=28721509 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28721509 #FOAvip English Wikipedia <ref>{{Cite pmid|28721509 }}</ref> Maintaining Patency of Vascular Access for Haemodialysis #MMPMID28721509 Inston N ; Al Shakarchi J ; Khawaja A ; Jones R Cardiovasc Eng Technol 2017[Sep]; 8 (3 ): 240-243 PMID28721509 show ga All types of vascular access, a necessity for haemodialysis, are prone to thrombosis and if untreated this results in failure. Thrombosis results from the combination of impaired blood flow, endothelial and vessel wall injury and a propensity towards pro-coagulative states, either intrinsic or aggravated by dialysis or dehydration. The treatment of access thrombosis relies on removal of the clot (thrombectomy) and treatment of the underlying problem. In most cases this is stenosis secondary to neointimal hyperplasia which can occur early (failure to mature) or later. Pharmacological approaches have largely been shown to be ineffective at prevention of thrombosis. The mainstay of preventing access failure may be in surveillance and detecting stenosis prior to occlusion although the optimal protocol to achieve this remains undefined. Management of thrombosed access is via either surgical and radiological approaches. Multiple techniques and devices are available for thrombectomy and the choice is usually based on local expertise and availability rather than evidence as few trials have been performed to allow robust comparisons. This paper outlines the basis of access thrombosis and discusses the currently available techniques for treatment. |Catheterization [MESH] |Humans [MESH] |Renal Dialysis/adverse effects/*methods [MESH] |Thrombectomy/*methods [MESH] |Thrombolytic Therapy/methods [MESH] |Thrombosis/etiology/prevention & control/*therapy [MESH] |Vascular Access Devices [MESH]Maintaining Patency of Vascular Access for Haemodialysis (epmc).pdf DeepDyve Pubget Overpricing